- Filed
- Apr 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 14, 2025 | 8.08M sh |
| Stock Repurchased | Q1 2025 · Feb 28, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Feb 29, 2024 | $170.38K |
| Cash And Equivalents | Q1 2025 · Feb 28, 2025 | $223.12K |
| Cash And Equivalents | Q1 2025 · Nov 30, 2024 | $560.96K |
| Current Liabilities | Q1 2025 · Feb 28, 2025 | $21.72M |
| Current Liabilities | Q1 2025 · Nov 30, 2024 | $21.6M |
| Total Liabilities | Q1 2025 · Feb 28, 2025 | $79.04M |
| Total Liabilities | Q1 2025 · Nov 30, 2024 | $77.89M |
| Current Assets | Q1 2025 · Feb 28, 2025 | $12.51M |
| Current Assets | Q1 2025 · Nov 30, 2024 | $12.55M |
| Total Assets | Q1 2025 · Feb 28, 2025 | $64.38M |
| Total Assets | Q1 2025 · Nov 30, 2024 | $64.68M |
| Total Assets restated | Q1 2025 · Nov 30, 2023 | $64.68M |
| Shares Diluted | Q1 2025 · Feb 29, 2024 | 8.33M sh |
| Dividends Paid | Q1 2025 · Feb 29, 2024 | $0 |
| Capex | Q1 2025 · Feb 29, 2024 | $457.72K |
| Operating Cash Flow | Q1 2025 · Feb 29, 2024 | −$356.87K |
| Stockholders Equity | Q1 2025 · Feb 29, 2024 | −$10.34M |
| Stockholders Equity | Q1 2025 · Nov 30, 2023 | −$11.03M |
| Eps Diluted | Q1 2025 · Feb 29, 2024 | $0.07 |
| Eps Basic | Q1 2025 · Feb 29, 2024 | $0.07 |
| Sga Expense restated | Q1 2025 · Feb 29, 2024 | $4.43M |
| Rd Expense | Q1 2025 · Feb 29, 2024 | $502.89K |
| Net Income | Q1 2025 · Feb 29, 2024 | $556.24K |
| Operating Income | Q1 2025 · Feb 29, 2024 | $821.22K |
| Cost Of Revenue restated | Q1 2025 · Feb 29, 2024 | $2.07M |